Enzalutasun 40mg Capsule

About

Enzalutasun 40mg Capsule is an advanced androgen receptor inhibitor primarily utilized in the comprehensive treatment of prostate cancer. This medication functions by precisely blocking the effects of androgens, which are male hormones like testosterone, known to fuel the growth and proliferation of prostate cancer cells. By binding with high affinity to the androgen receptor, Enzalutasun effectively prevents the receptor from translocating to the nucleus and activating genes that are crucial for cancer cell survival and proliferation. This multi-faceted mechanism helps to significantly slow down the progression of the disease and has demonstrated efficacy across various stages, including metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Its targeted action provides a crucial therapeutic option, managing disease progression by reducing tumor growth, delaying time to chemotherapy, and ultimately improving overall patient outcomes, often used in conjunction with androgen deprivation therapy (ADT) to maximize its therapeutic effect.

Uses

• Treatment of metastatic castration-resistant prostate cancer (mCRPC).
• Treatment of metastatic hormone-sensitive prostate cancer (mHSPC).
• Management of non-metastatic castration-resistant prostate cancer (nmCRPC).
• Used when prostate cancer has spread to other parts of the body.

Directions For Use

Take Enzalutasun 40mg Capsule orally as directed by your physician, usually once daily with or without food. Swallow the capsule whole; do not chew, crush, or open it.

Benefits

• Slows the progression of prostate cancer.
• Extends overall survival in treated patients.
• Reduces the risk of skeletal-related events.
• Improves quality of life for patients.
• Effective in both pre- and post-chemotherapy settings.
• Offers a targeted approach to cancer therapy.

Side Effects

• Fatigue
• Hot flashes
• High blood pressure
• Headache
• Diarrhea
• Nausea
• Back pain
• Joint pain
• Peripheral edema
• Muscle weakness
• Decreased appetite
• Seizures (rare but serious)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may worsen certain side effects like fatigue or liver strain. Consult your doctor.
• Pregnancy - Enzalutasun is not for use in women. It can cause fetal harm if administered to a pregnant woman.
• Breastfeeding - Enzalutasun is not for use in women. It is unknown if it is excreted in human milk.
• Liver - Use with caution in patients with severe hepatic impairment. Dose adjustments may be necessary.
• Kidney - Generally safe for use in patients with mild to moderate renal impairment. Severe impairment may require monitoring.
• Lung - No specific contraindications for lung conditions, but monitor for any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.